Asthma and COPD are two of the fastest growing disease states. There
are 17 million Americans with asthma and 15 million with COPD (by 2010
there will be 30 million with COPD. COPD is often undiagnosed in its
early stages, especially in smokers, who are most at risk and as a
result not receiving treatment.
Since early detection and treatment of COPD can positively influence
the disease course, it is important to screen those patients at risk.
The Microlife is the ideal tool to use as a quick check of lung
function to highlight signs of disease as early as possible.